Press Releases July 27, 2026 04:05 PM

Quantum-Si to Report Second Quarter 2026 Financial Results on August 13, 2026

Quantum-Si announces Q2 2026 earnings release and conference call scheduled for August 13, 2026

By Marcus Reed
Share
Twitter Reddit Facebook LinkedIn
QSI

Quantum-Si Incorporated, a proteomics technology company specializing in single-molecule protein analysis, will report its second quarter 2026 financial results on August 13, 2026, with a conference call hosted by its CEO and CFO to discuss the results and provide a business update.

Quantum-Si to Report Second Quarter 2026 Financial Results on August 13, 2026
QSI
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Quantum-Si to report Q2 2026 financial results on August 13, 2026.
  • Executive leadership will host a conference call to discuss results and business updates.
  • Company focuses on innovative single-molecule protein analysis technology impacting proteomics and biotechnology sectors.

BRANFORD, Conn., July 27, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will report financial results for the second quarter 2026 on Thursday, August 13, 2026. Jeff Hawkins, President and Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM EDT.

Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events and Presentations.

Alternatively, individuals can register here to receive a dial-in number and personalized PIN to participate in the call. An archived webcast of the event will be available for replay following the event.

About Quantum-Si Incorporated
Quantum-Si is transforming proteomics with a benchtop platform that brings single-molecule protein analysis to every lab, everywhere. The Company’s platform enables real-time kinetic-based detection and allows researchers to move beyond traditional, multistep workflows and directly access dynamic, functional protein insights with unparalleled resolution. By making protein analysis simpler, faster, and more informative, Quantum-Si is accelerating proteomic discoveries to improve the way we live. Learn more at quantum-si.com or follow us on LinkedIn or X.

Investor & Media Contact
Jeff Keyes
Chief Financial Officer
[email protected]

Source: Quantum-Si Incorporated


Risks

  • Financial performance risks depending on Q2 2026 results impacting investor sentiment.
  • Market adoption risk of Quantum-Si's novel proteomics technology influencing growth trajectory.
  • Competitive risks in proteomics and biotech sectors affecting future business prospects.

More from Press Releases

Sachem Capital Reports Third Quarter 2026 Results Nov 16, 2026 Inter&Co Delivers Record 3Q26 Net Income of US$76.1 Million, With Strong Growth, Higher Margin and Better Efficiency Nov 12, 2026 Super League to Report Third Quarter 2026 Financial Results on Monday, November 16, 2026 Nov 12, 2026 UroGen Reports $68.0 Million of ZUSDURI Revenue and Provides Third Quarter 2026 Financial Results and Highlights Nov 4, 2026 BioVie Announces Pricing of $4.74 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules Nov 4, 2026